The Current Ratio as of December 2025 (TTM) for AlzeCure Pharma AB (publ) (ALZCUR.ST) is 4.75

According to AlzeCure Pharma AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 4.75. This represents a change of 42.33% compared to the average of 3.34 of the last 4 quarters.

AlzeCure Pharma AB (publ) (ALZCUR.ST) Historical Current Ratio (quarterly & annually)

How has ALZCUR.ST Current Ratio performed in the past?

The mean historical Current Ratio of AlzeCure Pharma AB (publ) over the last ten years is 16.79. The current 4.75 Current Ratio has changed 2.73% with respect to the historical average. Over the past ten years (40 quarters), ALZCUR.ST's Current Ratio was at its highest in in the December 2018 quarter at 51.41. The Current Ratio was at its lowest in in the September 2017 quarter at 0.

AlzeCure Pharma AB (publ) (ALZCUR.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AlzeCure Pharma AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AlzeCure Pharma AB (publ) (ALZCUR.ST) Average Current Ratio

How has ALZCUR.ST Current Ratio performed in the past?

The current Current Ratio of AlzeCure Pharma AB (publ) (ALZCUR.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AlzeCure Pharma AB (publ) (ALZCUR.ST) Current Ratio vs. Peers

How is ALZCUR.ST’s Current Ratio compared to its peers?

AlzeCure Pharma AB (publ)’s Current Ratio is greater than Nanexa AB (publ) (2.08), greater than Mentice AB (publ) (0.97), greater than Physitrack PLC (0.66), greater than Boule Diagnostics AB (publ) (1.10), greater than Enorama Pharma AB (publ) (0.71), less than Karolinska Development AB (publ) (7.99), greater than IRLAB Therapeutics AB (publ) (1.30), greater than Klaria Pharma Holding AB (publ.) (0.06), greater than Lipum AB (publ) (0.62), less than AcuCort AB (8.28),

Build a custom stock screener for AlzeCure Pharma AB (publ) (ALZCUR.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AlzeCure Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AlzeCure Pharma AB (publ) (ALZCUR.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AlzeCure Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.